Ahead of the traceability in operation forum 2017 Pharma IQ conducted some market research to pinpoint the concerns and priorities of those in the more mature phases of serialisation. Commentary supplied by Pasi Kemppainen, Executive Consultant, Pharma Serialization and Traceability.
Pharma IQ presents this A-Z of one of the market's most affordable gene editing technique.
Pharma IQ explores the overage battle within clinical trial supply.
Last week, key figures in the biopharma manufacturing industry came together to shape the future of the industry, exchange best practice tips and spot the new opportunities on the horizon for the market.
Download this troubleshooting guide to explore the important aspects to consider with compound and biosample management IT issues.
Pharma IQ revisits the compound and biobanking markets to pinpoint any shifts or new trends in the market.
We spoke to CRISPR experts Robin Ketteler and Lorena Benedetti to find out about their work within CRISPR, insights on where the technique is heading and the field’s exciting developments.
Unsurprisingly, it can be a challenge for the industry to keep pace with all of these entities and the best practices that they are putting forward. In response to this, Pharma IQ has created this snapshot guide to a election of bodies active within the single-use-systems market to provide insight into their achievements over the past year and... Read more